Present status of vaccines for rubella.
D000818:Animals; D000917:Antibody Formation; D000956:Antigens, Viral; D002648:Child; D046508:Culture Techniques; D004198:Disease Susceptibility; D004285:Dogs; D004372:Ducks; D005260:Female; D000882:Haplorhini; D006801:Humans; D007109:Immunity; D007668:Kidney / Q000473:pathology; D008431:Maternal-Fetal Exchange; D009305:Nasopharynx / Q000382:microbiology; D011247:Pregnancy; D011817:Rabbits; D012409:Rubella / Q000276:immunology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000009:adverse effects*; D012412:Rubella virus / Q000276:immunology / Q000302:isolation & purification; D013997:Time Factors; D014613:Vaccines, Attenuated
D000956:Antigens, Viral; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated